Skip to content
HEAL-SL

Sub-studies

Studies run on the HEAL-SL national sampling frame.

The same national sample and trained field teams that track deaths can answer focused public health questions quickly.

All sub-studies

8 studies · 4 ongoing · 3 completed · 1 planned

Bar chart of adults at each step of the AMRI pre-implementation pilot: 213 approached, 211 consented, 203 first dummy vaccination, 200 randomised, 185 second and 171 third dummy vaccination
OngoingFrom 17 Feb 2026

Adult Malaria Reduction Intervention Trial (AMRI)

An individually randomised, double-blind, placebo-controlled phase 2 trial of the R21/Pfs230 malaria vaccine in adults, recruiting through HEAL-SL sampling units. A pre-implementation pilot with dummy vaccination ran in Bo District in February 2026.

Bo

Bar charts of deaths among adults admitted to Bo Government Hospital: 30% in severe and 12.4% in non-severe malaria in 2019, and 18.5% in the 2022 to 2023 cohort
Completed29 Sept 2022 – 20 Sept 2023

The malaria study

Adults admitted with fever to Bo Government Hospital: a 2019 chart review and a 2022 to 2023 cohort recruited by HEAL-SL staff. Deaths had a verbal autopsy by HEAL-SL staff and minimally invasive tissue sampling (MITS) by CHAMPS.

Bo

Dot chart of the planned genomics sample: about 60 adults from each of 11 ethnolinguistic groups
PlannedFrom 1 Aug 2026

Sierra Leone Genomics Study

A planned cross-sectional genomic study of about 660 adults from 11 ethnolinguistic groups, using HEAL-SL enumeration data to choose communities. Ethics review is in progress and recruitment has not started.

Njala University · National Public Health Agency of Sierra Leone · University of Oxford · BGI Research